Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rua Life Sciences PLC
F:AOHA
|
UK |
|
V
|
Vaiv Company Inc
KOSDAQ:301300
|
KR |
Rua Life Sciences is a UK medical technology company that develops and commercializes products for surgery and implanted devices. Its work centers on biomaterials and tissue-based technologies that can be used in areas such as cardiovascular repair and other specialist procedures. In simple terms, it sells medical products and technology built to replace or repair damaged tissue and to help other device makers improve their own products.
The company makes money in a few ways: by selling its own medical devices and components, by supplying biomaterial technology to other companies, and by earning fees or royalties from licensing that technology. Its main customers are hospitals, surgeons, and medical device manufacturers. That gives it a place in the healthcare value chain between laboratory research and the finished products used in operating rooms.
What makes the business different is that it is not just a single-device seller. It combines product sales with intellectual property and licensing around specialized biomaterials, so it can earn income from both its own branded offerings and from partners who use its technology. That mix makes it more of a niche medical materials and device company than a broad healthcare supplier.
© 2026 Alpha Spread Limited. All Rights Reserved.
www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more